The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Global prevalence and epidemiological trends of Hashimoto's thyroiditis in adults: A systematic review and meta-analysis
Open accessAbstract
Objective: Although Hashimoto's thyroiditis is associated with cardiovascular disease and malignancy, the global status of Hashimoto's thyroiditis is not well characterized across regions. Our objective was to evaluate the prevalence and trends of Hashimoto's thyroiditis in adults in regions with different economic income levels around the world. Methods: For this systematic review and meta-analysis, we searched PubMed, Embase, MEDLINE, Scopus, and Web of Science databases, and 48 random-effects representative studies from the inception to June 2022 were included without language restrictions to obtain the overall prevalence of Hashimoto's thyroiditis in adults worldwide. In addition, we stratified by time of publication, geographic region, economic level of the region of residence, gender, diagnostic method, etc. Results: A total of 11,399 studies were retrieved, of which 48 met the research criteria: 20 from Europe, 16 from Asia, five from South America, three from North America, and three from Africa. Furthermore, there are two projects involving 19 countries and 22,680,155 participants. The prevalence of Hashimoto's thyroiditis was 7.5 (95%CI 5.7–9.6%), while in the low-middle-income group the prevalence was 11.4 (95%CI 2.5–25.2%). Similarly, the prevalence was 5.6 (95%Cl 3.9–7.4%) in the upper-middle-income group, and in the high-income group, the prevalence was 8.4 (95%Cl 5.6–11.8). The prevalence of Hashimoto's varied by geographic region: Africa (14.2 [95% CI 2.5–32.9%]), Oceania (11.0% [95% CI 7.8–14.7%]), South America and Europe 8.0, 7.8% (95% Cl 0.0–29.5%) in North America, and 5.8 (95% Cl 2.8–9.9%) in Asia. Although our investigator heterogeneity was high (I 2), our results using a sensitivity analysis showed robustness and reliability of the findings. People living in low-middle-income areas are more likely to develop Hashimoto's thyroiditis, while the group in high-income areas are more likely to develop Hashimoto's thyroiditis than people in upper-middle-income areas, and women's risk is about four times higher than men's. Conclusions: Global Hashimoto's thyroiditis patients are about four times as many as males, and there are discrepancies in the regions with different economic levels. In low-middle-income areas with a higher prevalence of Hashimoto's thyroiditis, especially countries in Africa, therefore local health departments should take strategic measures to prevent, detect, and treat Hashimoto's thyroiditis. At the same time, the hidden medical burden other diseases caused by Hashimoto's thyroiditis should also be done well. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier: CRD 42022339839.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY
TUNBRIDGE, W. M. G., EVERED, D. C., HALL, R., APPLETON, D., BREWIS, M., CLARK, F., EVANS, J. G., YOUNG, E., BIRD, T., & SMITH, P. A. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb01340.x · Cited by 2,674
Hoy, D., Brooks, P., Woolf, A., Blyth, F., March, L., Bain, C., Baker, P., Smith, E., & Buchbinder, R. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.11.014 · Cited by 2,555 · cited 1×
“We used an existing checklist modified by Hoy D to assess the quality of included studies (6).”
MethodInflammation and cancer: An ancient link with novel potentials
Perwez Hussain, S., & Harris, C. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23173 · Cited by 1,097
Effect of Iodine Intake on Thyroid Diseases in China
Teng, W., Shan, Z., Teng, X., Guan, H., Li, Y., Teng, D., Jin, Y., Yu, X., Fan, C., Chong, W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054022 · Cited by 742
Self-citationHashimotos' thyroiditis: epidemiology, pathogenesis, clinic and therapy
Ragusa, F., Fallahi, P., Elia, G., Gonnella, D., Paparo, S. R., Giusti, C., Churilov, L. P., Ferrari, S. M., & Antonelli, A. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.101367 · Cited by 655
The incidence and prevalence of thyroid autoimmunity
McLeod, D. S. A., & Cooper, D. S. (2012) · Endocrine · doi:10.1007/s12020-012-9703-2 · Cited by 608
The World Incidence and Prevalence of Autoimmune Diseases is Increasing
Lerner, A., Jeremias, P., & Matthias, T. (2016) · International Journal of Celiac Disease · doi:10.12691/ijcd-3-4-8 · Cited by 508
The Spectrum of Thyroid Disorders in an Iodine-Deficient Community: The Pescopagano Survey1
Aghini-Lombardi, F., Antonangeli, L., Martino, E., Vitti, P., Maccherini, D., Leoli, F., Rago, T., Grasso, L., Valeriano, R., Balestrieri, A., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5508 · Cited by 347
Prevalence of vitamin D deficiency in Africa: a systematic review and meta-analysis
Mogire, R. M., Mutua, A., Kimita, W., Kamau, A., Bejon, P., Pettifor, J. M., Adeyemo, A., Williams, T. N., & Atkinson, S. H. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30457-7 · Cited by 317
Interplay between inflammation and cancer
(2020) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.09.004 · Cited by 290
The Spectrum of Thyroid Disorders in an Iodine-Deficient Community: The Pescopagano Survey
Aghini-Lombardi, F. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.561 · Cited by 288
Low Population Selenium Status Is Associated With Increased Prevalence of Thyroid Disease
Wu, Q., Rayman, M. P., Lv, H., Schomburg, L., Cui, B., Gao, C., Chen, P., Zhuang, G., Zhang, Z., Peng, X., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2222 · Cited by 265
The Pathogenesis of Hashimoto’s Thyroiditis: Further Developments in our Understanding
Ajjan, R. A., & Weetman, A. P. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1548832 · Cited by 259
The Prevalence of Undiagnosed Thyroid Disorders in a Previously Iodine-Deficient Area
Völzke, H., Lüdemann, J., Robinson, D. M., Spieker, K. W., Schwahn, C., Kramer, A., John, U., & Meng, W. (2003) · Thyroid · doi:10.1089/105072503768499680 · Cited by 256
Pedersen, I. B., Knudsen, N., Jørgensen, T., Perrild, H., Ovesen, L., & Laurberg, P. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01633.x · Cited by 221
DNA Damage in Inflammation-Related Carcinogenesis and Cancer Stem Cells
Ohnishi, S., Ma, N., Thanan, R., Pinlaor, S., Hammam, O., Murata, M., & Kawanishi, S. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/387014 · Cited by 207
Population Based Study of 12 Autoimmune Diseases in Sardinia, Italy: Prevalence and Comorbidity
Sardu, C., Cocco, E., Mereu, A., Massa, R., Cuccu, A., Marrosu, M. G., & Contu, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032487 · Cited by 185
Meta-analysis of Observational Studies
Greenwood, D. C. (2012) · Modern Methods for Epidemiology · doi:10.1007/978-94-007-3024-3_10 · Cited by 179
Teng, X., Shan, Z., Chen, Y., Lai, Y., Yu, J., Shan, L., Bai, X., Li, Y., Li, N., Li, Z., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1041 · Cited by 173
Self-citationLi, Y., Teng, D., Shan, Z., Teng, X., Guan, H., Yu, X., Fan, C., Chong, W., Yang, F., Dai, H., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2368 · Cited by 170
Self-citationLombardi, F. A., Fiore, E., Tonacchera, M., Antonangeli, L., Rago, T., Frigeri, M., Provenzale, A. M., Montanelli, L., Grasso, L., Pinchera, A., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2960 · Cited by 164
O'Leary, P. C., Feddema, P. H., Michelangeli, V. P., Leedman, P. J., Chew, G. T., Knuiman, M., Kaye, J., & Walsh, J. P. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02424.x · Cited by 163
Mikulska, A. A., Karaźniewicz‐Łada, M., Filipowicz, D., Ruchała, M., & Główka, F. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126580 · Cited by 151
Konno, N., Yuri, K., Taguchi, H., Miura, K., Taguchi, S., Hagiwara, K., & Murakami, S. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb01006.x · Cited by 133
Vitamin D status indicators in indigenous populations in East Africa
Luxwolda, M. F., Kuipers, R. S., Kema, I. P., van der Veer, E., Dijck-Brouwer, J., & Muskiet, F. A. J. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0421-6 · Cited by 127
Prentice, L., Phillips, D. I. W., Sarsero, D., Beever, K., McLachlan, S. M., & Smith, B. R. (1990) · European Journal of Endocrinology · doi:10.1530/acta.0.1230493 · Cited by 124
Camargo, R. Y. A., Tomimori, E. K., Neves, S. C., Rubio, I. G. S., Galrão, A. L., Knobel, M., & Medeiros-Neto, G. A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0192 · Cited by 116
Benvenga, S., & Trimarchi, F. (2008) · Thyroid · doi:10.1089/thy.2007.0234 · Cited by 103
Prevalence of Incidental Thyroid Disease in a Relatively Low Iodine Intake Area
Tomimori, E. K., Pedrinola, F., Cavaliere, H., Knobel, M., & Medeiros-Neto, G. A. (1995) · Thyroid · doi:10.1089/thy.1995.5.273 · Cited by 96
Hashimoto's thyroiditis as a risk factor for thyroid cancer
Feldt‐Rasmussen, U. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000570 · Cited by 95
Cancer Risk in Hashimoto’s Thyroiditis: a Systematic Review and Meta-Analysis
Hu, X., Wang, X., Liang, Y., Chen, X., Zhou, S., Fei, W., Yang, Y., & Que, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.937871 · Cited by 94
Self-citationHashimoto's thyroiditis – an independent risk factor for papillary carcinoma
Uhliarová, B., & Hajtman, A. (2017) · Brazilian Journal of Otorhinolaryngology · doi:10.1016/j.bjorl.2017.08.012 · Cited by 80
Racial and Age-related Differences in Incidence and Severity of Focal Autoimmune Thyroiditis
Okayasu, I., Hara, Y., Nakamura, K., & Rose, N. R. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/101.6.698 · Cited by 72
Kurata, S., Ishibashi, M., Hiromatsu, Y., Kaida, H., Miyake, I., Uchida, M., & Hayabuchi, N. (2007) · Annals of Nuclear Medicine · doi:10.1007/s12149-007-0030-2 · Cited by 69
SERUM-THYROTROPHIN IN SYMPTOM-LESS AUTOIMMUNE THYROIDITIS
Gordin, A., Saarinen, P., Heinonen, O. P., & Lamberg, B. ‐. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90353-4 · Cited by 51
Dingle, P., Ferguson, A., Horn, D. B., et al. (1966) · PubMed · Cited by 47
Troshina, E. A., Platonova, N. M., & Panfilova, E. A. (2021) · Problems of Endocrinology · doi:10.14341/probl12433 · Cited by 47
Increased Incidental Thyroid Cancer in Patients With Subclinical Chronic Lymphocytic Thyroiditis
Jackson, D. G., Handelsman, R. S., Farrá, J. C., & Lew, J. I. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.07.025 · Cited by 42
Camargo, R. Y. A., Tomimori, E. K., Neves, S. C., Knobel, M., & Medeiros-Neto, G. A. (2006) · Clinics · doi:10.1590/s1807-59322006000400006 · Cited by 41
Nagata, K., Takasu, N., Akamine, H., Ohshiro, C., Komiya, I., Murakami, K., Suzawa, A., & NOMURA, T. (1998) · Endocrine Journal · doi:10.1507/endocrj.45.797 · Cited by 37
Okayasu, I., Hatakeyama, S., Tanaka, Y., Sakurai, T., Hoshi, K., & Lewis, P. D. (1991) · The Journal of Pathology · doi:10.1002/path.1711630312 · Cited by 36
Thyroid antibodies in northern Norway: prevalence, persistence and relevance
Bryhni, B., Aanderud, S., Sundsfjord, J., Rekvig, O. P., & Jorde, R. (1996) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1996.488823000.x · Cited by 35
Incidence of thyroid diseases in Zhejiang Province, China, after 15 years of salt iodization
Gu, F., Ding, G., Lou, X., Wang, X., Mo, Z., Zhu, W., Zhou, J.-S., & Mao, G. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.04.003 · Cited by 28
Low level autoantibodies can be frequently detected in the general Australian population
Deshpande, P., Lucas, M., Brunt, S. J., Lucas, A., Hollingsworth, P., & Bundell, C. S. (2016) · Pathology · doi:10.1016/j.pathol.2016.03.014 · Cited by 28
Prevalence of thyroid antibodies in Nigerian patients
Okosieme, O. E., Taylor, R., Ohwovoriole, A. E., Parkes, A. B., & Lazarus, J. H. (2006) · QJM · doi:10.1093/qjmed/hcl137 · Cited by 26
The prevalence of autoimmune thyroiditis after universal salt iodisation in Sri Lanka
Fernando, R., Chandrasinghe, P. C., & Pathmeswaran, A. (2012) · Ceylon Medical Journal · doi:10.4038/cmj.v57i3.4702 · Cited by 24
Teng, X., Shi, X., Shan, Z., Jin, Y., Guan, H., Li, Y., Yang, F., Wang, W., Tong, Y., & Teng, W. (2007) · Biological Trace Element Research · doi:10.1007/s12011-007-8036-0 · Cited by 22
Population-based Study of 24 Autoimmune Diseases Carried Out in a Brazilian Microregion
Júnior, D. S. T., de Oliveira, C. M., & de Assis, E. M. (2019) · Journal of Epidemiology and Global Health · doi:10.2991/jegh.k.190920.001 · Cited by 22
Flores-Rebollar, A., Moreno-Castañeda, L., Vega-Servín, N. S., López-Carrasco, G., & Ruiz-Juvera, A. (2015) · PubMed · doi:10.3305/nh.2015.32.2.9246 · Cited by 21
Yu, Z., Yu, Y., Wan, Y., Fan, J., Meng, H., Li, S., Wang, Y., Wang, T., & Ling, R. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4928 · Cited by 19
Döbert, N., Balzer, K., Diener, J., Wegscheider, K., Vaupel, R., & Grünwald, F. (2008) · PubMed · Cited by 16
Balzer, K., Diener, J., Wegscheider, K., Vaupel, R., Grünwald, F., & Döbert, N. (2008) · Nuklearmedizin - NuclearMedicine · doi:10.3413/nukmed-0166 · Cited by 16
Kim, H. J., Kazmi, S. Z., Kang, T., Sohn, S. Y., Kim, D., Hann, H. J., & Ahn, H. S. (2021) · Thyroid · doi:10.1089/thy.2020.0213 · Cited by 14
Pilli, T., Cardinale, S., Dalmiglio, C., Secchi, C., Fralassi, N., Cevenini, G., Cairano, G. D., Maino, F., Forleo, R., Pacini, F., et al. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0972-3 · Cited by 13
Influence of Rapid Urbanization on Thyroid Autoimmune Disease in China
Chen, Y., Han, B., Yu, J., Chen, Y., Cheng, J., Zhu, C., Xia, F., Wang, N., & Lu, Y. (2021) · International Journal of Endocrinology · doi:10.1155/2021/9967712 · Cited by 11
Self-citationTammaro, A., Pigliacelli, F., Fumarola, A., & Persechino, S. (2016) · PubMed · Cited by 9
Jóźków, P., Lwow, F., Słowińska-Lisowska, M. R., & Mędraś, M. (2017) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/60862 · Cited by 9
Vecchiatti, S. M. P., Lin, C. J., Capelozzi, V. L., Longatto‐Filho, A., & Bisi, H. (2014) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000094 · Cited by 6
Yu, L. J., Chen, D., Cui, J., Zhong, X., Yang, G.-R., Niu, M.-J., & Yang, J. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0137-3 · Cited by 6
Izić, B., Čustović, A., Caluk, S., Fejzić, H., Šarić-Kundalić, B., & Husejnović, M. Š. (2021) · Materia Socio Medica · doi:10.5455/msm.2021.33.288-292 · Cited by 5
Metadata
- Authors
- Hu, X., Chen, Y., Shen, Y., Tian, R., Sheng, Y., & Que, H.
- Venue
- Frontiers in Public Health
- Publisher
- Frontiers Media SA
- Published
- 2022-10-13
- Volume
- 10
- Pages
- 1020709-1020709
- ISSN
- 2296-2565 (ISSN-L)
- OpenAlex
- W4304890757
- Cited by
- 279
- References
- 62
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.